II. Epidemiology
- Incidental Adrenal Mass found on up to 3-4% of Abdominal CTs or MRIs
- Incidental Adrenal Masses found in 20% of autopsies
III. Differential Diagnosis of Incidental Adrenal Mass
- Adrenal Adenoma (51%)
- Non-functioning adenoma
- Functioning adenoma
- Metastatic cancer (31%)
- Adrenal Carcinoma (1-4%)
- Adrenal Cyst (4%)
- Pheochromocytoma (4%)
- Adrenal Hyperplasia (2%)
- Lipoma (2%)
- Myelolipoma (2%)
IV. Labs
-
Pheochromocytoma Screening
- Consider plasma free metanephrines (in all patients)
- 24-hour Urine Metanephrines
- 24-hour Urine Vanillylmandelic Acid (VMA)
-
Cushing's Syndrome Screening
- Dexamethasone Suppression Test (in all patients)
- 24-hour Urinary Free Cortisol level
-
Hyperaldosteronism Screening (hypertensive patients)
- Serum Potassium
- Plasma Aldosterone to renin activity ratio
V. Imaging
-
CT Abdomen
- With IV contrast
- Low attenuation lesions (<10 Hounsfield Units) is more consistent with benign lesions
- With delayed-phase (to perform washout calculations)
- Adrenal carcinoma has a low washout
- With IV contrast
- MRI Abdomen with Chemical Shift
- Chemical shift confirms lipid-rich adenoma
- Indicated if CT with IV contrast contraindicated
- Fluorodeoxyglucose-positron emission testing (FDG-PET)
- Indicated for lesions not definitively characterized on CT or MRI
- High Test Sensitivity for malignancy
- Decreased Test Specificity for malignancy (False Positives possible)
VI. Evaluation: Reassuring findings suggestive of benign Adrenal Mass
- No history of other malignancy (lowers risk to 0.3% chance of cancer)
- Reassuring imaging findings suggestive of benign mass
- Lesions smaller than 4 cm with smooth borders
- Lipid-containing lesions
- CT with low attenuation (<10 Hounsfield Units) homogeneous mass
- MRI with signal loss on out-of-phase imaging
- Rapid-washout of IV iodinated contrast
VII. Indications: Follow-up Imaging
- Distinguish benign Lesions versus cancer
- Distinguish functioning versus non-functioning
VIII. Evaluation: Protocol
- Adrenal Mass on CT Scan <1 cm in greatest diameter (especially if fatty or cystic consistency)
- No further evaluation needed
- Adrenal Mass on CT Scan >4 cm in greatest diameter
- Evaluate endocrine labs above (especially to rule out Pheochromocytoma)
- Imaging
- Biopsy unless clearly benign (e.g. adrenal cyst, myelolipoma)
- Consult with surgery regarding possible excision
- Adrenal Mass 1-4 cm and lipid containing lesion on initial imaging (see above)
- Consider evaluating endocrine labs above (especially to rule out Pheochromocytoma)
- Repeat unenhanced CT Abdomen in 12 months to confirm no change
- Adrenal Mass 1-4 cm and not a lipid containing lesion
- Evaluate endocrine labs above (especially to rule out Pheochromocytoma)
- Perform CT Abdomen with IV contrast and delayed phase (or MRI as alternative)
- If CT or MRI non-diagnostic, consider FDG-PET
- Referral
- Endocrinology for functional adenomas
- General surgery for suspicious or non-diagnostic imaging
IX. References
- Cook (1996) Am J Med 101:88-94 [PubMed]
- Grumbach (2003) Ann Intern Med 138:424-9 [PubMed]
- Higgins (2001) Am Fam Physician 63:288-99 [PubMed]
- Hitzeman (2014) Am Fam Physician 90(11): 784-9 [PubMed]
- Yoh (2008) Ann Nucl Med 22(6): 513-9 [PubMed]
- Young (2007) N Engl J Med 356(6): 601-10 [PubMed]
- Willatt (2010) Am Fam Physician 81(11): 1361-6 [PubMed]